A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors

Clinical trial NCT06643754 · RECRUITING

Trial details

NCT number: NCT06643754
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-12-10
Primary completion: 2027-12-30
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.